FreeTender
Accepting bidsitbPoland

Poland – Various medicinal products – Dostawa produktu leczniczego Niwolumab + Relatlimab, PN-166/26/TM

Poland – Various medicinal products – Delivery of Niwolumab + Relatlimab, PN-166/26/TMEnglish, machine translated

Issued by Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy · via TED — Tenders Electronic Daily (EU)

Published
18 Nov 2026
Closes
18 Dec 2026, 23:59 UTC
Reference
803177-2026
Location
Poland
Sector
Healthcare & Pharma
Type
goods

At a glance

Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy in Poland has published an invitation to bid in healthcare & pharma: “Poland – Various medicinal products – Dostawa produktu leczniczego Niwolumab + Relatlimab, PN-166/26/TM”. Submissions close on 18 December 2026, 31 days from today. Quote reference 803177-2026 in any correspondence with the buyer. One document is attached to this notice. FreeTender has recorded 68 notices from this buyer since 2026, 9 of them currently open. There are 977 open healthcare & pharma notices in Poland on FreeTender. Bids are submitted to the buyer through TED — Tenders Electronic Daily (EU), not through FreeTender.

Key requirements

Taken from the notice by FreeTender. The tender document on the official portal is binding — check it, and any corrigendum, before you bid.

To bid on EU public procurement

Most EU buyers ask for the European Single Procurement Document (ESPD) as a self-declaration with the bid. Submission is on the e-procurement platform named in the notice.

English summary

Machine translated from Polish by FreeTender. The original notice below is the binding text.

1. Delivery of Niwolumab + Relatlimab medicinal product is the subject of the order. 2. Detailed description of the order includes Annex 2 to SWZ. Lots Lot 1 — Niwolumab + Relatlimab: The subject of the order is the supply of the medicinal product Niwolumab + Relatlimab, as described in Annex 2 to SWZ. Buyer: Maria Skłodowska-Curie National Institute of Oncology - State Research Location: Warsaw Buyer country: POL Procedure: open CPV code: 33690000 Full notice, tender documents and how to bid are on the official TED page (link above).

Details

1. Przedmiotem zamówienia jest dostawa produktu leczniczego Niwolumab + Relatlimab. 2. Szczegółowy opis przedmiotu zamówienia zawiera Załącznik nr 2 do SWZ.

Lots

Lot 1 — Niwolumab + Relatlimab: Przedmiotem zamówienia jest dostawa produktu leczniczego Niwolumab + Relatlimab, szczegółowo opisanych w Załączniku nr 2 do SWZ.

Buyer: Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy

Buyer country: POL

Procedure: open

CPV code: 33690000

Full notice, tender documents and how to bid are on the official TED page (link above).

Context for bidders

We hold 68 notices from Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie - Państwowy Instytut Badawczy, going back to August 2026 — 9 of them still open. They buy mostly in Healthcare & Pharma, Facility Management & Cleaning and IT & Telecom. There are 977 open Healthcare & Pharma tenders in Poland. This one closes in 31 days.

Similar Healthcare & Pharma tenders

Explore Poland

Documents

Before you bid on this tender

A quick checklist to help you decide whether to bid and prepare a compliant submission for this healthcare & pharma opportunity. Always verify the details on the official source.

  • Confirm the exact closing date and time (and time zone) on the official portal — deadlines are strict and can be revised by a corrigendum.
  • Read the full notice and every attached document, including the scope, specifications and any bill of quantities or terms of reference.
  • Check the eligibility criteria — prior similar experience, annual turnover, certifications and registrations — and make sure you qualify before investing effort.
  • Prepare any earnest-money deposit (EMD) or bid security and the required formats early; missing or wrongly-formatted documents are a common cause of rejection.
  • Note how bids must be submitted (online or physical), in what format, and whether a digital signature or portal registration is required.
  • Watch for corrigenda and clarifications right up to the deadline — requirements and dates can change.

More Healthcare & Pharma tenders

All Healthcare & Pharma tenders →

FreeTender mirrors this notice for reference. Verify the details and bid on the official portal.

Verify & apply on the official portal →